NCT04433455 Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients
| NCT ID | NCT04433455 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huashan Hospital |
| Condition | Hemodialysis |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2020-06-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2020-06-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this observational study, the investigators evaluate the influencing factors of cerebrovascular disease and cognition in hemodialysis patients.
Eligibility Criteria
Inclusion Criteria: 1. maintenance hemodialysis patients who are younger than 85 years old and older than 50 years old, regardless of gender 2. dialysis vintage is greater than 3 months; Exclusion Criteria: 1. Those with severe infection and anemia (Hb \<60g / L); 2. Those with severe mental illness, metabolic diseases and immune system diseases; 3. Patients with abnormal liver function
Contact & Investigator
Jing Chen
PRINCIPAL INVESTIGATOR
Huashan Hospital
Frequently Asked Questions
Who can join the NCT04433455 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Hemodialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04433455 currently recruiting?
Yes, NCT04433455 is actively recruiting participants. Contact the research team at chenjing1998@fudan.edu.cn for enrollment information.
Where is the NCT04433455 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04433455 clinical trial?
NCT04433455 is sponsored by Huashan Hospital. The principal investigator is Jing Chen at Huashan Hospital. The trial plans to enroll 20 participants.